Vaccination against human papillomavirus
- PMID: 18056601
- PMCID: PMC2096521
- DOI: 10.1503/cmaj.1070118
Vaccination against human papillomavirus
Comment on
-
Human papillomavirus, vaccines and women's health: questions and cautions.CMAJ. 2007 Aug 28;177(5):484-7. doi: 10.1503/cmaj.070944. Epub 2007 Aug 1. CMAJ. 2007. PMID: 17671239 Free PMC article. No abstract available.
References
-
- Brown D. HPV type 6/11/16/18 vaccine: first analysis of cross-protection against persistent infection, cervical intraepithelial neoplasia (CIN), and adenocarcinoma in situ (AIS) caused by oncogenic HPV types in addition to 16/18. Presented at the 47th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy; 2007 Sep 17–20; Chicago (IL).
-
- Brisson M. The health and economic burden of HPV infection, genital warts, cervical dysplasia and cervical cancer in Canada [presentation]. Presented at the 7th Canadian Immunization Conference; 2006 Dec 3; Winnipeg (MB). Available: www.phac-aspc.gc.ca/cnic-ccni/2006/pres/_pdf-sun-dim-dec03/4-Hall-B-Vira... (accessed 2007 Oct 26).
-
- Lee JH, Smith RJ. Recurrent respiratory papillomatosis: pathogenesis to treatment review. Curr Opin Otolaryngol Head Neck Surg 2005;13:354-9. - PubMed
-
- Smith EM, Ritchie JM, Summersgill KF, et al. Human papillomavirus in oral exfoliated cells and risk of head and neck cancer. J Natl Cancer Inst 2004;96:449-55. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources